Share on StockTwits

GenVec (NASDAQ:GNVC) posted its quarterly earnings results on Tuesday. The company reported ($0.10) EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.15) by $0.05, Analyst Ratings reports.

Shares of GenVec (NASDAQ:GNVC) opened at 2.15 on Tuesday. GenVec has a 52-week low of $0.25 and a 52-week high of $4.25. The stock’s 50-day moving average is $2.30 and its 200-day moving average is $2.72. The company’s market cap is $37.1 million.

GenVec, Inc (NASDAQ:GNVC) is a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines.

Receive News & Ratings for GenVec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GenVec and related companies with Analyst Ratings Network's FREE daily email newsletter.